Alexza Pharmaceuticals Inc fka ALXA

[Scifi1]

03/18 Roth Capital briefing (chart 33): "Goal is to finalize commercial strategy by end of Q1 2013". Note this statement does not say that the strategy will be executed but rather seems to indicate that one of the two strategies (chart 33); 1) Traditional Partnership or 2) CSO and royalty company, will be selected (amoung multiple potential partners). So, those of us looking for a "deal" in the next few days will possibly see a "strategy selection" instead. This argument is supported by the recent addition of Peter W. Schineller as Senior Vice President and Chief Commercial Officer who would need time to react. Another price drop is likely in store if this occurs however, this would give management another quarter (+) to execute the commercial strategy before launch in Q3.

Reference:

http://wsw.com/webcast/roth27/alxa/